<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04897659</url>
  </required_header>
  <id_info>
    <org_study_id>CIL 2019-48 bis</org_study_id>
    <nct_id>NCT04897659</nct_id>
  </id_info>
  <brief_title>Left Bundle Branch Block (LBBB) After IntuityTM</brief_title>
  <official_title>Persistent Left Bundle Branch Block After Rapid-Deployment Aortic Valve Replacement: Incidence, Long-term Prognostic and Predictive Factors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aimed to evaluate incidence, prognosis and predictive factors of new-onset of&#xD;
      persistent left bundle branch block (LBBB) after rapid-deployment aortic valve replacement&#xD;
      (RD-AVR) with the IntuityTM bioprosthesis.&#xD;
&#xD;
      It was an observational, retrospective and single-center study. Two hundred and seventy-four&#xD;
      consecutive patients without any baseline ventricular conduction disorder or previous&#xD;
      permanent pacemaker or defibrillator implantation who underwent RD-AVR with the IntuityTM&#xD;
      valve were included. Twelve-lead electrocardiogram and transthoracic echocardiography were&#xD;
      performed preoperatively, postoperatively, at discharge, 1-month, and 1-year. Incidence,&#xD;
      prognosis and predictive factors of new-onset of persistent LBBB were evaluated.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Actual">May 1, 2021</completion_date>
  <primary_completion_date type="Actual">April 1, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of NOP-LBBB (new onset of persistent left bundle branch block)</measure>
    <time_frame>at 1 year</time_frame>
    <description>QRS duration ≥ 120 ms with QS or rS patterns on the V1 lead, a large notched R wave in D1, aVL, V5 and V6 and the absence of Q wave in V5 and V6, according to the recommendations of the American Heart Association. NOP-LBBB was persistence of LBBB on the 12-lead recording electrocardiogram (ECG) at discharge from hospital.</description>
  </primary_outcome>
  <enrollment type="Actual">274</enrollment>
  <condition>Aortic Valve Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Two hundred and seventy-four consecutive patients without any baseline ventricular&#xD;
        conduction disorder or previous permanent pacemaker or defibrillator implantation who&#xD;
        underwent rapid-deployment aortic valve replacement (RD-AVR) with the IntuityTM valve were&#xD;
        included. Twelve-lead electrocardiogram and transthoracic echocardiography were performed&#xD;
        preoperatively, postoperatively, at discharge, 1-month, and 1-year.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  rapid-deployment aortic valve replacement (RD-AVR) with the Edwards Intuity™&#xD;
             bioprosthesis for severe aortic valve stenosis&#xD;
&#xD;
          -  between July 2012 and May 2018&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  preoperative permanent pacemaker or defibrillator,&#xD;
&#xD;
          -  complete intraventricular conductive disorder defined by a QRS width ≥ 120 ms.&#xD;
&#xD;
          -  absence of patient's authorization for anonymous publication of their clinical data&#xD;
             for research purposes.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assistance Publique Hôpitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 18, 2021</study_first_submitted>
  <study_first_submitted_qc>May 18, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 21, 2021</study_first_posted>
  <last_update_submitted>May 28, 2021</last_update_submitted>
  <last_update_submitted_qc>May 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
    <mesh_term>Bundle-Branch Block</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

